Huahui Health
Clinical trials sponsored by Huahui Health, explained in plain language.
-
New hope for hepatitis b: 48-Week drug trial launches
Disease control Recruiting nowThis study tests a new drug called HH-006 in 45 adults with chronic hepatitis B. Participants will receive the drug for 48 weeks and be monitored for changes in virus levels and liver function. The goal is to see if the drug can safely control the infection and reduce the amount …
Phase: PHASE2 • Sponsor: Huahui Health • Aim: Disease control
Last updated Jun 17, 2026 12:08 UTC
-
New hope for hepatitis d: phase 3 trial of libevitug launches
Disease control Recruiting nowThis study tests a new medicine called libevitug in 160 adults with chronic hepatitis D, a serious liver infection. The goal is to see if libevitug can lower the virus in the blood and improve liver health. Participants will receive the drug and be monitored for 48 weeks.
Phase: PHASE3 • Sponsor: Huahui Health • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC